Deva Holding A.S. (IST:DEVA)

Market Cap	11.40B
Revenue (ttm)	14.70B
Net Income (ttm)	612.12M
Shares Out	200.02M
EPS (ttm)	3.06
PE Ratio	18.63
Forward PE	n/a
Dividend	0.29 (0.51%)
Ex-Dividend Date	Jun 25, 2024

Volume	134,936
Average Volume	457,645
Open	56.85
Previous Close	56.80
Day's Range	56.60 - 57.15
52-Week Range	53.55 - 97.80
Beta	-0.41
RSI	49.51
Earnings Date	Aug 15, 2025

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.